Literature DB >> 2964430

The effects of enoximone (MDL-17043) on forearm venous circulation in healthy volunteers and patients with heart failure.

A Branzi1, C Berardi, R M Ferretti, E Beato, G Magnani, G Melandri, R Zannoli, B Magnani.   

Abstract

The effect of intravenous enoximone on forearm venous circulation was studied in ten healthy volunteers (group A) and in ten patients with NYHA class III-IV congestive heart failure (group B). Distensibility of the forearm capacitance vessels was assessed from pressure-volume curves by venous occlusion plethysmography using a mercury-in-rubber strain gauge. Three recordings each at 3-min intervals were obtained before the infusion and again 20 min after completion of the infusion. Venous volume changes (VV) at congesting pressures of 10, 20, and 30 mmHg before and after enoximone were compared. Forearm muscle blood flow was also measured by venous occlusion plethysmography; electrocardiogram, heart rate, and cuff blood pressure were recorded throughout. Enoximone at a dose of 1 mg/kg body weight was infused over 10 min through a peripheral vein in group A and via a central line in group B. In group A, the effect of the injection vehicle was also assessed. VV10, VV20, and VV30 did not differ from baseline values after enoximone in both groups A and B. The vehicle caused a small but significant degree of venoconstriction in group A (VV20, 2.64 +/- 0.9 to 2.48 +/- 0.83 ml/100 ml, P less than 0.05; VV30, 3.47 +/- 1.27 to 3.33 +/- 1.20 ml/100 ml, P less than 0.05), which could be explained by an acute response to local pain from the infusion. This effect was not evident following enoximone, perhaps as a result of its counterbalancing vasodilating action to venoconstriction induced by acute pain.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2964430     DOI: 10.1007/bf02058791

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  28 in total

1.  Release of norepinephrine from the heart by vasoactive amines.

Authors:  C A CHIDSEY; D C HARRISON; E BRAUNWALD
Journal:  Proc Soc Exp Biol Med       Date:  1962-03

2.  Occurrence and function of cyclic nucleotides in blood vessels.

Authors:  D H Namm; J P Leader
Journal:  Blood Vessels       Date:  1976

3.  MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.

Authors:  S A Rubin; L Tabak
Journal:  J Am Coll Cardiol       Date:  1985-06       Impact factor: 24.094

4.  Effect of MDL 17043, a new cardiotonic agent, on myocardial oxygen consumption.

Authors:  L E Roebel; R J Hodgeman; N L Velayo; R C Dage; J K Woodward
Journal:  J Pharm Pharmacol       Date:  1983-04       Impact factor: 3.765

5.  Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance.

Authors:  M H Crawford; K L Richards; M T Sodums; G T Kennedy
Journal:  Am J Cardiol       Date:  1984-04-01       Impact factor: 2.778

6.  Filling and emptying of the low-pressure blood vessels of the human forearm.

Authors:  E Brown; D M Greenfield; J S Goei; G Plassaras
Journal:  J Appl Physiol       Date:  1966-03       Impact factor: 3.531

7.  Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.

Authors:  D J Kereiakes; C Viquerat; P Lanzer; E H Botvinick; R Spangenberg; M Buckingham; W W Parmley; K Chatterjee
Journal:  Am Heart J       Date:  1984-11       Impact factor: 4.749

8.  Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.

Authors:  D Kereiakes; K Chatterjee; W W Parmley; B Atherton; D Curran; A Kereiakes; R Spangenberg
Journal:  J Am Coll Cardiol       Date:  1984-11       Impact factor: 24.094

9.  Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.

Authors:  D K Amin; P K Shah; F G Shellock; S Hulse; G Brandon; R Spangenberg; H J Swan
Journal:  Am Heart J       Date:  1985-01       Impact factor: 4.749

Review 10.  Inotropic drugs and their mechanisms of action.

Authors:  H Scholz
Journal:  J Am Coll Cardiol       Date:  1984-08       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.